The 4th International Online Conference on Vaccines

We are pleased to announce the 4th International Online Conference on Vaccines (IOCV 2027), which will be held online and promoted by the open access MDPI journal Vaccines (ISSN 2076-393X, IF 3.4).

Vaccines remain one of the most powerful tools in modern medicine, and we stand at a uniquely transformative moment in their development. Cutting-edge technologies, including mRNA platforms, structure-based antigen design, single-cell sequencing, and artificial intelligence-driven immunogen optimization, are reshaping how we conceive, design, and evaluate vaccines. These advances are not only accelerating responses to emerging threats but also unlocking progress against some of the most persistent challenges in global health, including HIV and malaria. After decades of setbacks, next-generation HIV vaccine strategies leveraging broadly neutralizing antibodies and novel immunogen scaffolds are showing renewed promise, while landmark approvals of malaria vaccines mark a critical step forward that must now be matched by concerted efforts for ensuring global implementation and equitable access. IOCV 2027 brings together researchers, clinicians, and public health practitioners to address these scientific frontiers alongside the practical realities of vaccine deployment, uptake, and impact in diverse populations.

The IOCV 2027 invites researchers from academia, as well as vaccine practitioners, to contribute original findings, novel ideas, scientific concepts, and technological advancements related to the following:

• Advances in Vaccine Platforms and Delivery Systems;
• Innate Immunity, Trained Immunity, and Vaccine Responses;
• Adjuvants and Immune Modulators in Modern Vaccines;
• Vaccines for Chronic and Difficult-to-Control Infections, Including HIV and Malaria;
• Correlates of Protection and Systems Vaccinology;
• Emerging Pathogens and Pandemic Preparedness.

As a fully online conference, IOCV 2027 provides a unique opportunity for researchers worldwide to participate without travel constraints, facilitating the real-time exchange of the latest findings and innovative ideas.

Your contributions and engagement are vital to the success of this 4th edition of the IOCV. Together, we have an opportunity to drive progress in overcoming the most pressing challenges in vaccine science today, ranging from conquering HIV and malaria to ensuring that life-saving vaccines reach every corner of the world. We look forward to your participation in shaping the future of vaccine research!

Kind regards,
Prof. Dr. Michael Bukrinsky
The George Washington University, Washington DC, USA

More News about MDPI Conferences